Roth Capital lowered the firm’s price target on Insperity (NSP) to $54 from $56 and keeps a Buy rating on the shares. The company’s Q1 results exceeded estimates, and the firm believes that margin recovery and profit improvement in 2026 are tracking ahead of expectations, the analyst tells investors in a research note. Unit growth is challenged by higher attrition due to repricing efforts, but the profit recovery during 2026 and long-term growth potential of HRScale makes Insperity a compelling opportunity, the firm added.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NSP:
